Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

DCM vs HIT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HIT Wins Head-to-Head Institutional Verdict (4–1 across 6 Pillars · 8–2 Matrix Metrics)

HIT Overall Winner 6-Pillar Tally: DCM 1 – 4 HIT (1 Tie) Matrix Metrics: DCM 2 – 8 HIT

As of Nov 20, 2026, Health In Tech, Inc. (HIT) is the stronger overall head-to-head candidate over DCM (DCM) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DCM carries a Unified Composite Score of 48.8/100 (HOLD) at $2.82 (N/M Forward P/E, N/A operating margin), whereas HIT carries 39.6/100 (SELL) at $0.38 (8.8x Forward P/E, -45.8% operating margin).

  • Composite vs. Pillar Nuance: While DCM currently prints a higher short-term Unified Composite Score (48.8/100 HOLD vs. HIT 39.6/100 SELL), HIT captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (-45.8% vs. N/A operating margin) and revenue trajectory (-22.4% vs. N/A YoY).
  • Technical & Structure Timing Caution: DCM trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile HIT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 33.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DCM vs HIT
DCM US Equity
DCM
Institutional Equity
$2.82
-6.62% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol N/A
Unified Composite Score
48.8 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
HIT NASDAQ Head-to-Head Winner
Health In Tech, Inc. Class A Common Stock
Insurance Agents, Brokers & Service
$0.38
+12.36% 1D
Market Cap $27.1M
TTM Revenue $31M
Forward P/E 8.8x
Beta / 30D Vol 0.95β · 152% Vol
Unified Composite Score
39.6 / 100 SELL
Tech 48.0 Fund 45.0 Flow 50.0 Mom 45.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -21.8%), weak momentum, RSI 34
RSI-14: 33.9 · SMA20: $0.52 · SMA50: $0.66

6-Pillar Scorecard Institutional Category Breakdown (DCM 1 – 4 HIT)

Columns: Metric · DCM · HIT
1. Valuation Multiples HIT
Forward P/E N/M 8.8x
Trailing P/E N/M 8.8x
PEG Ratio N/M N/M
EV / Revenue N/M 0.7x
2. Growth & Scale HIT
Revenue Growth (YoY) N/A -22.4%
Earnings Growth (YoY) N/A +10.3%
TTM Revenue (USD) N/A $31M
Market Cap N/A $27.1M
3. Profitability & Quality HIT
Gross Margin N/A 50.5%
Operating Margin N/A -45.8%
Net Profit Margin N/A -37.1%
Return on Equity (ROE) N/A -76.6%
4. Balance Sheet & Cash Flow HIT
Cash Generation (TTM) N/A -$7.6M
Cash Flow Margin N/A -24.7%
Net Cash / Leverage N/A ROE $6.4M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning DCM
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Software - Application Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DCM (2) vs HIT (8)
Institutional Metric DCM HIT Criterion Row Edge
Market Capitalization
Scale
N/A $27.1M Larger Scale HIT
Trailing P/E Ratio
Valuation
N/M 8.8x Lower Multiple HIT
Forward P/E Ratio
Valuation
N/M 8.8x Lower Multiple HIT
Revenue Growth (YoY)
Growth
N/A -22.4% Higher Growth HIT
Operating Margin (TTM)
Profitability
N/A -45.8% Higher Margin HIT
Net Profit Margin
Profitability
N/A -37.1% Higher Margin HIT
Return on Equity (ROE)
Capital Efficiency
N/A -76.6% Higher ROE HIT
52-Week Range Position
Momentum
0% ($3–$5) 5% ($0–$2) Stronger Trend HIT
Beta / 30D Volatility
Risk Regime
N/A 0.95β · 152% Vol Lower Realized Risk DCM
Unified Institutional Score
Composite Signal
48.8 / 100 (HOLD) 39.6 / 100 (SELL) Higher Composite DCM
Trailing 12M Revenue (USD)
Operating Scale
N/A $31M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 50.5% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) -$7.6M ($6.4M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon DCM +6.73 pp
DCM: -26.75% · HIT: -33.48%
3M Horizon DCM +5.32 pp
DCM: -34.42% · HIT: -39.74%
6M Horizon DCM +5.32 pp
DCM: -34.42% · HIT: -39.74%
1Y Horizon DCM +5.32 pp
DCM: -34.42% · HIT: -39.74%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DCM vs HIT. Trailing 12-month operating profitability (DCM N/A vs HIT -45.8%) and valuation multiples (DCM N/M vs HIT 8.8x Forward P/E) are benchmarked directly in Pillar 4 below.

DCM ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
HIT ADR TTM Benchmark FX-Normalized USD
TTM Revenue$31M
Gross Margin50.5%
Op. Margin-45.8%
ROE / Fwd P/E-76.6% · 8.8x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DCM UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact DCM Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
HIT BREAKDOWN
174d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact HIT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DCM Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
HIT Moat Profile Cyclical / Execution-Driven Positioning
Software - Application Operator
Competes within the Software - Application value chain with $27.1M market capitalization and -45.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ DCM vs HIT Key Questions & Quantitative Answers

As of Nov 20, 2026, Health In Tech, Inc. (HIT) is the stronger overall head-to-head candidate over DCM (DCM) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DCM carries a Unified Composite Score of 48.8/100 (HOLD) at $2.82 (N/M Forward P/E, N/A operating margin), whereas HIT carries 39.6/100 (SELL) at $0.38 (8.8x Forward P/E, -45.8% operating margin). Composite vs. Pillar Nuance: While DCM currently prints a higher short-term Unified Composite Score (48.8/100 HOLD vs. HIT 39.6/100 SELL), HIT captures the overall institutional head-to-head verdict (8–2 matrix metrics and 4–1 across the 6 pillars) due to superior fundamental profitability (-45.8% vs. N/A operating margin) and revenue trajectory (-22.4% vs. N/A YoY). Technical & Structure Timing Caution: DCM trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI N/A); meanwhile HIT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 33.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HIT leads the Growth & Scale pillar: DCM posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with HIT at -22.4% YoY revenue growth and +10.3% YoY earnings growth on $31M TTM revenue (50.5% gross margin, -45.8% operating margin). On trailing 12-month operating scale, DCM generates N/A in USD-normalized revenue versus $31M for HIT. In operating R&D and SG&A reinvestment, DCM deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for HIT.

HIT screens cheaper on headline valuation multiples. DCM trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas HIT trades at 8.8x Forward P/E, 8.8x Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-24.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DCM (N/A ROE) versus HIT (-76.6% ROE) capital efficiency.

In options market volatility and institutional positioning, DCM carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (N/A realized risk). By comparison, HIT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.95β · 152% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.